UC San Francisco tests new class of MS drugs

Advances in MRI technology and cellular engineering are giving new hope to people fighting Multiple scleroris. SmartPlanet visits the University of California at San Francisco and talks to Prof. Emannuelle Waubant about new drug therapy that is reducing brain lesions and cutting down on relapse for patients.

This post was originally published on Smartplanet.com

Editorial standards